Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized, Parallel-Group Trial on PTK-ZK With or Without DTIC in Patients With Non-resectable Metastatic Malignant Melanoma

NCT00615160 is registered in ClinicalTrials.gov with Michael Weichenthal as lead sponsor.

NCT NCT00615160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00615160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized, Parallel-Group Trial on PTK-ZK With or Without DTIC in Patients With Non-resectable Metastatic Malignant Melanoma
Lead sponsor
Michael Weichenthal
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2006
Completion date
September 30, 2008
Enrollment
9 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma